entertainment -WSS

entertainment

author：knowledge 2025-09-29 01:39:13 - browse：18828

Stacks of silver coins surrounded by a medicare health insurance card — insurance coverage from STAT — A federal rule that could make Medicare reimbursement for breakthrough devices easier is slated for early summer. Adobe

WASHINGTON — A federal rule aiming to make reimbursement for breakthrough devices easier is slated for early summer, a Centers for Medicare and Medicaid Services official said on Thursday.

The agency has faced intense pressure from device makers frustrated with the slow pace of Medicare reimbursement decisions. Medical technology lobby AdvaMed sent CMS a strongly-worded letter in March asking why it has taken so long to get the breakthrough device program moving.

Dora Hughes, director of the clinical standards center at CMS, told attendees at the Medical Device Manufacturers’ Association conference the agency wanted to take the time to meaningfully address feedback sent during the comment period, which closed in August. She also noted the organization’s goal of releasing the final rule with a slate of other policies, including a rule clarifying the agency’s thinking on what kind of evidence would be needed to convince the agency that a given device is both reasonable and necessary.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： The Sacklers, horror, and ‘The Fall of the House of Usher’

focus

WSS

Free speech concerns arise in wake of journal editor Eisen's firing

Victims of gun violence feel impacts long after bullet wound

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Anesthesiologist group: stop taking Ozempic before surgery

Hepatitis C has a cure — but many Americans still lack access to it

A clever new way to fix Medicaid and graduate medical education

focus

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Cancer drug shortages should be causing more outrage

Supreme Court strikes down use of affirmative action

BioMarin wins approval for gene therapy to treat hemophilia A

Extreme heat events are a public health emergency

At least 13 dead in Texas as scorching temps continue

Guidelines to prevent youth baseball injuries need more muscle

Guidelines to prevent youth baseball injuries need more muscle

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

hotspot

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Biotech incubator Curie.Bio graduates its first startup

How one medical school became remarkably diverse

White House calls on federal agencies to crack down on AI abuses

Peter Hotez and the public health issue of online harassment

The cancer drug shortage isn’t new — and neither are the solutions

explore

Wikipedia

focus

knowledge